You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – A. Menarini Diagnostics and Credo Diagnostics Biomedical announced on Thursday an exclusive distribution agreement for Credo's SARS-CoV-2 assay kit and other assays for diagnosing respiratory syncytial virus and Group Strep A.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.